Published in J Pediatr on January 01, 1977
Field evaluation of vaccine efficacy. Bull World Health Organ (1985) 4.95
Measles and measles vaccine efficacy in a remote island population. Bull World Health Organ (1982) 1.10
Lassa fever. Effective therapy with ribavirin. N Engl J Med (1986) 6.38
Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med (1999) 5.85
A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis (1987) 5.27
Human asymptomatic Ebola infection and strong inflammatory response. Lancet (2000) 5.20
Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. Bull World Health Organ (1983) 4.81
Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission II. Descriptive epidemiology of malaria infection and disease among children. Am J Trop Med Hyg (1999) 4.24
A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis (1987) 3.51
Cultured endothelial cells produce a heparinlike inhibitor of smooth muscle cell growth. J Cell Biol (1981) 3.41
Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. BMJ (1995) 3.21
Clinical virology of Lassa fever in hospitalized patients. J Infect Dis (1987) 2.94
Regulation of acetylcholinesterase in neuroblastoma cells. Proc Natl Acad Sci U S A (1970) 2.89
The mosquito Anopheles stephensi limits malaria parasite development with inducible synthesis of nitric oxide. Proc Natl Acad Sci U S A (1998) 2.83
Descriptive analysis of Ebola virus proteins. Virology (1985) 2.65
Lassa fever in the United States. Investigation of a case and new guidelines for management. N Engl J Med (1990) 2.57
Inactivation of Lassa, Marburg, and Ebola viruses by gamma irradiation. J Clin Microbiol (1982) 2.44
Inhibition of rat arterial smooth muscle cell proliferation by heparin. II. In vitro studies. Circ Res (1980) 2.40
The efficacy of DPT and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age. Bull World Health Organ (1985) 2.35
Unsafe injections and the transmission of hepatitis B and C in a periurban community in Pakistan. Bull World Health Organ (2000) 2.33
The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan. Epidemiol Infect (1997) 2.27
Pathologic and virologic study of fatal Lassa fever in man. Am J Pathol (1982) 2.14
Ribavirin suppresses replication of lymphadenopathy-associated virus in cultures of human adult T lymphocytes. Lancet (1984) 2.12
Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiol Infect (2006) 2.09
Performance of screening mammography among women with and without a first-degree relative with breast cancer. Ann Intern Med (2000) 2.09
Management of heparin therapy: Controlled prospective trial. N Engl J Med (1975) 2.07
Acute sensorineural deafness in Lassa fever. JAMA (1990) 2.02
Biologic differences between strains of Ebola virus from Zaire and Sudan. J Infect Dis (1983) 1.94
Junin virus monoclonal antibodies: characterization and cross-reactivity with other arenaviruses. J Gen Virol (1989) 1.92
Filoviridae: a taxonomic home for Marburg and Ebola viruses? Intervirology (1982) 1.89
High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens. J Immunol (1995) 1.87
Diagnosis of Ebola haemorrhagic fever by RT-PCR in an epidemic setting. J Med Virol (2000) 1.79
Physicochemical inactivation of Lassa, Ebola, and Marburg viruses and effect on clinical laboratory analyses. J Clin Microbiol (1984) 1.78
Effective vaccine for lassa fever. J Virol (2000) 1.74
Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trial Group. Clin Infect Dis (2000) 1.73
Crimean Congo-haemorrhagic fever treated with oral ribavirin. Lancet (1995) 1.72
Nucleotide sequence of the glycoprotein gene and intergenic region of the Lassa virus S genome RNA. Virology (1986) 1.69
Evaluation of the polymerase chain reaction for diagnosis of Lassa virus infection. Am J Trop Med Hyg (1993) 1.66
Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections. Science (1987) 1.66
Development and evaluation of an enzyme-linked immunosorbent assay for Plasmodium vivax-VK247 sporozoites. J Med Entomol (1992) 1.64
Relation between circadian patterns in levels of circulating lipoprotein(a), fibrinogen, platelets, and related lipid variables in men. Am Heart J (2000) 1.58
Wound infection by an indigenous Pseudomonas pseudomallei-like organism isolated from the soil: case report and epidemiologic study. J Infect Dis (1977) 1.57
Human-to-human transmission of Pseudomonas pseudomallei. Ann Intern Med (1975) 1.52
A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy. BMJ (1988) 1.51
Identification of Plasmodium vivax sporozoites in mosquitoes using an enzyme-linked immunosorbent assay. Am J Trop Med Hyg (1985) 1.50
Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission I. Description of study site, general methodology, and study population. Am J Trop Med Hyg (1999) 1.49
Continuous in vitro propagation of the malaria parasite Plasmodium vivax. Proc Natl Acad Sci U S A (1997) 1.49
Hepatitis G virus in Karachi, Pakistan. Lancet (1996) 1.47
Biologic characteristics of interval and screen-detected breast cancers. J Natl Cancer Inst (2000) 1.44
Early diagnosis of perinatal HIV infection by detection of viral-specific IgA antibodies. JAMA (1991) 1.44
The Hamilton depression scale. Evaluation of objectivity using logistic models. Acta Psychiatr Scand (1981) 1.43
The nucleoprotein gene of Ebola virus: cloning, sequencing, and in vitro expression. Virology (1989) 1.42
Thrombin generation in non-cardioembolic stroke subtypes: the Hemostatic System Activation Study. Neurology (2004) 1.42
Epidemiology and control of Lassa fever. Curr Top Microbiol Immunol (1987) 1.40
HFRS after a wild rodent bite in the Haute-Savoie--and risk of exposure to Hantaan-like virus in a Paris laboratory. Lancet (1984) 1.38
Inability of Plasmodium knowlesi sporozoites to invade Anopheles freeborni salivary glands. Am J Trop Med Hyg (1985) 1.38
Viral hemorrhagic fever antibodies in Nigerian populations. Am J Trop Med Hyg (1988) 1.36
Frequency of spinocerebellar ataxia type 1, dentatorubropallidoluysian atrophy, and Machado-Joseph disease mutations in a large group of spinocerebellar ataxia patients. Neurology (1996) 1.36
Fractionation of low molecular weight heparin species and their interaction with antithrombin. J Biol Chem (1979) 1.36
Forest malaria in Bangladesh. II. Transmission by Anopheles dirus. Am J Trop Med Hyg (1982) 1.35
Antigenic relatedness between arenaviruses defined at the epitope level by monoclonal antibodies. J Gen Virol (1991) 1.35
Public health considerations in the management of meningococcal disease. Ann Intern Med (1975) 1.32
Taxol produces a predominantly sensory neuropathy. Neurology (1989) 1.32
Xanthurenic acid induces gametogenesis in Plasmodium, the malaria parasite. J Biol Chem (1998) 1.32
Lassa virus hepatitis: a study of fatal Lassa fever in humans. Am J Trop Med Hyg (1986) 1.31
Retracted The ERK signaling cascade inhibits gonadotropin-stimulated steroidogenesis. J Biol Chem (2001) 1.30
Prognostic significance of downregulated expression of the candidate tumour suppressor gene SASH1 in colon cancer. Br J Cancer (2006) 1.30
Trends in disease caused by Neisseria meningitidis: 1972 and 1973. J Infect Dis (1974) 1.29
Risk factors for typhoid fever in an endemic setting, Karachi, Pakistan. Epidemiol Infect (1998) 1.29
Hantaan virus: identification of virion proteins. J Gen Virol (1984) 1.27
HIV antibody seroprevalence and associated risk factors in sex workers, drug users, and prisoners in Sindh, Pakistan. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.26
Monoclonal antibodies to three strains of hantaviruses: Hantaan, R22, and Puumala. Arch Virol (1991) 1.26
Safe intensive-care management of a severe case of Lassa fever with simple barrier nursing techniques. Lancet (1985) 1.26
Rifampin chemoprophylaxis for household contacts of patients with invasive infections due to Haemophilus influenzae type b. J Pediatr (1981) 1.26
Protection of guinea pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virus. Virology (1989) 1.25
Nucleotide sequence of the Lassa virus (Josiah strain) S genome RNA and amino acid sequence comparison of the N and GPC proteins to other arenaviruses. Virology (1989) 1.25
Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene. Proc Natl Acad Sci U S A (1989) 1.25
Zolpidem for persistent insomnia in SSRI-treated depressed patients. J Clin Psychiatry (1999) 1.25
Detection of viral antigens in formalin-fixed specimens by enzyme treatment. Ann N Y Acad Sci (1983) 1.23
Risk of human infections with Crimean-Congo hemorrhagic fever virus in a South African rural community. Am J Trop Med Hyg (1992) 1.23
Clinical, epidemiologic, and therapeutic aspects of Lassa fever. Med Microbiol Immunol (1986) 1.22
Yersinia enterocolitica infection in a 4-month-old infant associated with infection in household dogs. J Pediatr (1976) 1.21
Readiness to adopt a self-management approach to chronic pain: the Pain Stages of Change Questionnaire (PSOCQ). Pain (1997) 1.21
Plasmodium vivax: gametocyte infectivity of naturally infected Thai adults. Parasitology (1991) 1.21
An imported case of Lassa fever with late appearance of polyserositis. J Infect Dis (1988) 1.21
Physiological and immunologic disturbances associated with shock in a primate model of Lassa fever. J Infect Dis (1987) 1.20
Experimental filovirus infections. Curr Top Microbiol Immunol (1999) 1.20
Experimental infection of rhesus monkeys with Lassa virus and a closely related arenavirus, Mozambique virus. J Infect Dis (1982) 1.20
Physicochemical properties of Marburg virus: evidence for three distinct virus strains and their relationship to Ebola virus. J Gen Virol (1988) 1.19
Anger expression and chronic pain. J Behav Med (1994) 1.19
The prevalence of infection with human immunodeficiency virus over a 10-year period in rural Zaire. N Engl J Med (1988) 1.19
Disease control programs in the United States. Control of streptococcal and poststreptococcal disease. JAMA (1978) 1.19
L-Tryptophan transport in human red blood cells. Biochim Biophys Acta (1980) 1.19
Epidemic streptococcal sore throat following a community picnic. JAMA (1976) 1.19
The Danish PET/depression project: clinical symptoms and cerebral blood flow. A regions-of-interest analysis. Acta Psychiatr Scand (2002) 1.18
Primary health care providers' recognition and diagnosis of mental disorders in their patients. Gen Hosp Psychiatry (1988) 1.18
Hematologic dysfunction in Lassa fever. J Med Virol (1988) 1.17
Human immunodeficiency virus isolated from a serum sample collected in 1976 in Central Africa. J Infect Dis (1987) 1.16
No evidence for increased risk of Lassa fever infection in hospital staff. Lancet (1986) 1.16
Elastase-like, esteroprotease activity in human and rabbit alveolar macrophage granules. Proc Soc Exp Biol Med (1971) 1.16
Case-control study of Mastomys natalensis and humans in Lassa virus-infected households in Sierra Leone. Am J Trop Med Hyg (1983) 1.16